Iovance Biotherapeutics Inc (IOVA) — Cash Flow-to-Debt Ratio
Iovance Biotherapeutics Inc (IOVA) has a Cash Flow-to-Debt Ratio of -0.39x as of September 2025, meaning its operating cash flow of $-78.70 Million could theoretically repay 0% of its total liabilities ($202.66 Million) in one year. Explore Iovance Biotherapeutics Inc (IOVA) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Iovance Biotherapeutics Inc Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Iovance Biotherapeutics Inc across 17 annual periods. Also explore how large is Iovance Biotherapeutics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Iovance Biotherapeutics Inc (2008–2024)
Year-by-year debt coverage analysis for Iovance Biotherapeutics Inc. For market capitalisation and broader financial context, see IOVA market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.76x | $-352.98 Million | $200.02 Million | ▲ +4.5% |
| 2023 | -1.85x | $-361.82 Million | $195.74 Million | ▼ -3.8% |
| 2022 | -1.78x | $-292.76 Million | $164.34 Million | ▼ -21.7% |
| 2021 | -1.46x | $-227.94 Million | $155.67 Million | ▲ +20.1% |
| 2020 | -1.83x | $-205.13 Million | $111.96 Million | ▲ +47.3% |
| 2019 | -3.48x | $-158.89 Million | $45.68 Million | ▲ +49.8% |
| 2018 | -6.92x | $-101.25 Million | $14.63 Million | ▲ +13.0% |
| 2017 | -7.96x | $-78.71 Million | $9.89 Million | ▼ -21.0% |
| 2016 | -6.58x | $-32.67 Million | $4.97 Million | ▲ +41.7% |
| 2015 | -11.28x | $-18.38 Million | $1.63 Million | ▼ -117.1% |
| 2014 | -5.20x | $-8.63 Million | $1.66 Million | ▼ -222.0% |
| 2013 | -1.61x | $-3.66 Million | $2.27 Million | ▼ -716.9% |
| 2012 | -0.20x | $-2.24 Million | $11.35 Million | ▲ +57.4% |
| 2011 | -0.46x | $-6.19 Million | $13.35 Million | ▲ +38.5% |
| 2010 | -0.75x | $-620.80K | $822.87K | ▼ -20.7% |
| 2009 | -0.62x | $-14.45K | $23.12K | ▲ +96.4% |
| 2008 | -17.22x | $-57.30K | $3.33K | — |